Geneos Therapeutics Closes its Series A3 Financing With Investment of $5 Million


— Proceeds Will Fund Completion of GT-30 Trial of Personalized Therapeutic Cancer Vaccine in Liver Cancer — — Shanghai-based SHC Added to Geneos’ Investor Syndicate — PLYMOUTH MEETING, Pa., Sept. 27, 2023 /PRNewswire/ — Geneos Therapeutics, a clinical stage biotherapeutics company…

Leave a Reply